MacroGenics (Germany) Today
| M55 Stock | EUR 3.17 0.04 1.28% |
Performance0 of 100
| Odds Of DistressLess than 26
|
MacroGenics is trading at 3.17 as of the 14th of December 2024. This is a 1.28 percent increase since the beginning of the trading day. The stock's lowest day price was 3.17. MacroGenics has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of November 2024 and ending today, the 14th of December 2024. Click here to learn more.
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. MacroGenics, Inc. was founded in 2000 and is headquartered in Rockville, Maryland. MACROGENICS INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 61.48 M outstanding shares. More on MacroGenics
Moving together with MacroGenics Stock
Moving against MacroGenics Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MacroGenics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MacroGenics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MacroGenics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Ezio Bonvini |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
MacroGenics (M55) is traded on Frankfurt Exchange in Germany and employs 427 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 350.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MacroGenics's market, we take the total number of its shares issued and multiply it by MacroGenics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MacroGenics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 61.48 M outstanding shares.
MacroGenics has accumulated about 272.14 M in cash with (143.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check MacroGenics Probability Of Bankruptcy
Ownership AllocationMacroGenics maintains a total of 61.48 Million outstanding shares. The majority of MacroGenics outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MacroGenics to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in MacroGenics. Please pay attention to any change in the institutional holdings of MacroGenics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MacroGenics Ownership Details
MacroGenics Risk Profiles
Although MacroGenics' alpha and beta are two of the key measurements used to evaluate MacroGenics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.33 | |||
| Semi Deviation | 4.39 | |||
| Standard Deviation | 4.42 | |||
| Variance | 19.55 |
MacroGenics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MacroGenics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Additional Information and Resources on Investing in MacroGenics Stock
When determining whether MacroGenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MacroGenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Macrogenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Macrogenics Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in MacroGenics Stock please use our How to Invest in MacroGenics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.